NCT03676569View on ClinicalTrials.gov

Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 15, 2015

Primary Completion Date

April 14, 2019

Study Completion Date

April 14, 2019

Conditions
Refractory Epilepsy
Interventions
BIOLOGICAL

ADRC transplantation in autoimmune refractory epilepsy

All Listed Sponsors
collaborator

Institute of Mother and Child, Warsaw, Poland

OTHER

lead

Mossakowski Medical Research Centre Polish Academy of Sciences

OTHER

NCT03676569 - Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy | Biotech Hunter | Biotech Hunter